Abridge vs Eleos Health (2026)
A health system with a behavioral health service line eventually asks whether its enterprise scribe covers it, and this is that question. Abridge is deployed at scale across health systems, with a full trust center and coverage spanning outpatient, inpatient and emergency care. Eleos is built only for behavioral health, including substance use treatment and field based care, and it carries outside audits that most of this category does not, including ISO/IEC 42001 certification of its AI management system and a combined SOC 2 Type II and HITRUST audit. The test is practical rather than philosophical: ask your general vendor to produce a psychiatric evaluation and a substance use encounter note from real audio. Most general scribes do not model those formats or the confidentiality rules attached to them, and that is what the specialist is selling.
- The adoption record is the deepest in the category, Best in KLAS in consecutive years across more than two hundred and fifty health systems, with a full trust center and named sub processors.
- One documentation contract across the whole organization is administratively simpler than an enterprise scribe plus a behavioral specialist.
- Coverage spans outpatient, inpatient and emergency settings with dozens of specialties, so most service lines are handled by the same product.
- It is built for behavioral health specifically, including substance use treatment and field based care, which have documentation structures and confidentiality rules general scribes do not model.
- Outside auditors have examined both its security and its AI management system, and its deployment, residency and data isolation are documented.
- Behavioural documentation carries protections beyond the general health privacy rule in many jurisdictions, and a product built for that context is defensible when the note is later read in a licensure or legal proceeding.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Abridge and Eleos Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Abridge | Eleos Health |
|---|---|---|
| Primary category | Ambient Scribes | Behavioral Health AI |
| Founded | 2018 | 2019 |
| Headquarters | Pittsburgh, Pennsylvania | Waltham, Massachusetts, United States |
| Website | abridge.com | eleos.health |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Abridge
-
Safety / governance
Abridge opened an Evaluation Dashboard in its Enterprise Portal for the governance and clinical informatics leaders at partner health systems.
Source -
EHR / interoperability
Abridge's October release lets outpatient clinicians on Epic capture orders during the visit.
Source -
Product / capability
Abridge launched pre bill review for clinical documentation integrity, coding and revenue cycle teams.
Source
Eleos Health
-
Product / capability
Eleos Health shipped version 10.0.17.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Abridge is an enterprise ambient AI platform that turns the clinician patient conversation into a structured, billable note inside the EHR, sold to health systems rather than to individual clinicians. It partners with more than 300 health systems, including Kaiser Permanente, Mayo Clinic, Johns Hopkins, Duke Health, Memorial Sloan Kettering, Northwell, UPMC, Sutter Health and NYU Langone, and won the KLAS Research award for Ambient AI in 2025 and 2026.
Source: AI Health Index, September 2026
Voice based AI for community based care, marketed as CareOps automation, serving community behavioral health and substance use disorder treatment organizations and, since 2025, home health, hospice and palliative care.
Source: AI Health Index, September 2026
Questions buyers ask
How do Abridge and Eleos Health work with the EHR?
For Abridge, the integration is embedded in Epic Haiku and Hyperdrive, so recording, review and the finished note stay in the Epic workflow with no copy and paste step and no parallel interface. The February 2024 Epic announcement described the path as running from recording conversations in Haiku to embedding generated notes in the patient chart in Hyperdrive.
Eleos also describes integrations with client systems over its own VPN without naming them. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 20, 2026. No vendor pays for placement.
How are Abridge and Eleos Health priced and sold?
Abridge reaches its 300+ health systems through institutional contracts rather than individual clinician signup, and there is no self serve path. The trust center lists a master services agreement among its legal documents, held behind an access request alongside the security documentation.
Eleos sells to provider organizations, community behavioral health, substance use disorder, home health and hospice agencies, through a demo and contract, and its site describes outcomes and time saved but not what drives the cost, whether clinicians, sessions, notes or modules. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 20, 2026. No vendor pays for placement.
How do Abridge and Eleos Health handle patient data?
With Abridge, the OpenAI listing indicates that content derived from the encounter reaches a third party model provider.
Eleos keeps the AI-generated note suggestions and user engagement data and states that it retains them for refining its models, together with minimal session identifying information: clinician ID, session date and time, client unique ID and name. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 20, 2026. No vendor pays for placement.
How much do Abridge and Eleos Health leave to the clinician?
For Abridge, a structured, specialty specific note is ready for review the moment the visit ends, and the clinician reviews and edits it before finalizing, with editing tools that adapt to individual preferences.
Eleos frames its product as augmented rather than autonomous intelligence: it drafts note content, which Eleos says covers about 80 percent of a typical progress note, and the provider reviews, tweaks and submits. Its Compliance product checks notes for documentation errors before claim submission, and Eleos states that it is not there to replace a provider's judgment about clinical care. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 20, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
This is a scoping question rather than a head to head. The honest test is whether your enterprise scribe handles behavioral documentation formats, substance use confidentiality rules and the field based visit, and most do not model any of them, so ask for a demonstration on a real psychiatric evaluation before assuming coverage.
Eleos states that session audio is deleted within one to two minutes and states its training position, but it executes a business associate agreement on request rather than publishing one, and it publishes no price at all. Its strongest study is small and single site while its marketing reaches further. Behavioral health audio is especially sensitive, and a general purpose scribe's retention and training terms were written for an outpatient office visit rather than a therapy session.